MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
NeuroSense Therapeutics Ltd. Ordinary Shares

NRSN

#3744
NeuroSense Therapeutics Ltd. Ordinary Shares
0.91
+2.25%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
0.91
0.91
Intervallo Annuale
0.68
2.60
Variazione giornaliera
+2.25%
Variazione Mensile
-1.09%
Variazione di 6 mesi
-19.47%
Variazione Annuale
-18.02%
Chiusura Precedente
0.89
Open
0.91
Bid
Ask
Low
0.91
High
0.91
Volume
1
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. NRSN
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 16.93 M
  • Employee 15
  • Founded 2017
  • CEO N/A
  • Website www.neurosense-tx.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
16.93 M Market capitalization
Price to earnings ratio
-2.22
Price to sales ratio
11.16 K
Dividends per share
—
Dividend yield %
—

Notizie

Investing Investing
NRSN
2026.02.09
Il titolo di Neurosense Therapeutics sale dopo aver ottenuto un brevetto australiano per PrimeC
Investing Investing
NRSN
2026.02.09
Neurosense Therapeutics stock rises after securing Australian patent for PrimeC
Investing Investing
NRSN
2025.12.22
Il titolo di Neurosense sale mentre il farmaco per l’Alzheimer mostra un profilo di sicurezza favorevole
Investing Investing
NRSN
2025.12.22
Neurosense stock rises as Alzheimer’s drug shows favorable safety profile
Investing Investing
NRSN
2025.06.02
NRSN stock touches 52-week high at $1.65 amid robust gains
Investing Investing
NRSN
2025.05.20
NRSN stock touches 52-week high at $1.52 amid growth optimism
Benzinga Benzinga
NRSN
2025.05.12
Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights - NeuroSense Therapeutics (NASDAQ:NRSN)
Benzinga Benzinga
NRSN PMN FRST
2025.05.12
This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday - NeuroSense Therapeutics (NASDAQ:NRSN), Primis Finl (NASDAQ:FRST)

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd